Headline
The latest stories from AHA Today.
In an alert this week, the Department of Health and Human Services’ Health Sector Cybersecurity Coordination Center (HC3) reminded health care providers and researchers to patch any vulnerabilities in their Picture Archiving Communication Systems that could expose patient records to unauthorized…
The AHA announced key leadership appointments to reflect the increasing focus and importance of health equity and workforce in the association’s strategic activities.
As the nation grapples with the complicated logistics of fair and efficient vaccine distribution, this conversation with two senior officials from the National Urban League explores best practices and strategies hospitals and health systems can use to reach Black, Latinx and underserved communities…
Enrollment in Medicaid and the Children’s Health Insurance Program increased 5.6% between July 2019 and July 2020, driven largely by the economic downturn created by the COVID-19 pandemic, according to a report released by the Medicaid and CHIP Payment and Access Commission.
The Centers for Medicare & Medicaid Services posted additional information to help health care providers implement six new ICD-10 diagnosis codes for reporting conditions related to COVID-19 on medical claims effective Jan. 1. The information includes updated coding guidelines, code…
Drug overdose deaths increased 18% over the 12-month period that ended in May to a record 81,230, according to a new Centers for Disease Control and Prevention advisory.
The Food and Drug Administration authorized a prescription BinaxNOW COVID-19 test for use by patients at home, in partnership with a telehealth service that will take users through the sample collection process and assist in reading and understanding the results.
AHA launched #MyWhy, a social media campaign that amplifies health care workers’ voices on the importance of getting vaccinated against COVID-19.
The AHA released a new edition of the COVID-19 Snapshot, highlighting the critical needs of hospitals and health systems during the deepening public health emergency.
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.